Clinical Trial Update: Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating olanzapine for cancer-associated appetite loss in patients with advanced esophageal, gastric, colorectal, biliary tract, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Carcinoma
• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Lung Cancer

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Advanced Malignant Solid Neoplasm, Advanced Biliary Tract Carcinoma | Phase 2 | Status: RECRUITING